TRILLIUM THERAPEUTICS INC. 6,550,000 Common Share Units 12,200,000 Series II Non-Voting Convertible First Preferred Share Units UNDERWRITING AGREEMENTUnderwriting Agreement • February 25th, 2019 • Trillium Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 25th, 2019 Company Industry Jurisdiction